Adjuvant Bevacizumab in High-Risk HER2-Negative Breast Cancer The ASCO Post, 14 Sep 2018 By Matthew Stenger Posted: 8/6/2018 10:55:28 AM Last Updated: 9/14/2018 3:24:37 PM Advertisement The addition of bevacizumab…